INTRODUCTION
Heavy chain disease is characterized by the presence of relatively homogeneous polypeptide chains that are immunochemically and structurally related to heavy polypeptide chains of normal immunoglobulins. In all previously reported cases (1-4) abnormal serum and/or urine protein has been related to -y-polypeptide chains. Franklin, Lownstein, Bigelow, and Meltizer (1) in their original description of the disease, and also Osserman and Takatsuki (2) , showed that the characteristic anomalous immunoglobulin is, in fact, most closely related to the papain-produced Fc-fragment of normal IgG and does not correspond to the whole heavy polypeptide chain. The Fc-fragment contains the COOH-terminal half of two identical y-heavy chains (5) . Since proteins are normally synthesized from the amino to the carboxyl terminus, Received for publication 7 October 1968. the findings of a carboxyl terminal half of a heavy chain in this disease raises important questions about the mechanism of -y-heavy chain disease protein (-yHCD) synthesis and the relation of this mechanism to the normal synthesis of immunoglobulins. Recognition of a new case of heavy chain disease (JM)' made possible studies at the cellular level which showed that this protein is a secretory product of cells and not a result of extracellular catabolism. It was determined that the cells synthesizing the anomalous heavy chain do not synthesize immunoglobulin light chains. Furthermore, structural studies were done to determine whether or not the normal N-terminal portion of the y-heavy chain was present in the -yHCD molecules.
METHODS
Immunoelectrophoretic and Ouchterlony analytic technics and preparation of specific antisera have been previously described (6) .
Purification of J. M. urinary paraprotein. Urine was first precipitated with 30% (v/w) (NH4) 2SO4; The supernate was then brought to 50%o (NH4)2 SO4 (v/w) saturation, the precipitate collected and desalted either by extensive dialysis against 0.14 M NaCl or by passage through a column of Sephadex G-25, eluting with 0.07 M NaCl. Geon-Pevikon block electrophoresis was then performed (6) and appropriate fractions were collected and concentrated by (Diaflo) ultrafiltration. DEAE-cellulose chromatography (Whatman DE-52 microgranular cellulose) was performed on fractions from block electrophoresis with a gradient elution from 0.05 M to 0. Purity of the final product was assessed by immunoelectrophoresis and Ouchterlony analysis at a sample concentration of at least 20 mg/ml. Several preparations were also tested in the ultracentrifuge and these showed only a single component.
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Reduction and alkylation, tryptic digestions, and peptide maps were performed as described by Appella and Ein (7) .
Preparation of Fc-fragment. A solution of purified IgG3-myeloma protein (Ben) was digested with papain by the method of Porter. Digestion proceeded at 37°C for only 2 hr because of the lability of IgG3-myeloma proteins to papain digestion. Fc-fragment was separated from undigested protein and Fab-fragment by stepwise elution from DEAEcellulose (Whatman De-52 microgranular cellulose). Purity of the Fc-fragment was assessed by immunoelectrophoresis and Ouchterlony analysis at a concentration of 20 mg/ml and found to be free of contaminants by these criteria.
Immunofluorescence. Preparation of fluorescein-and rhodamine-conjugated antisera and staining of slides were performed as described by Finegold, Fahey, and Dutcher (8) .
Biosynthesis. Biosynthetic studies were based on the procedure of Hochwald, Thorbecke, and Asofsky (9), as modified by Sanders et al. (10) .
Ultracentrifugation. Ultracentrifugation was performed in the Spinco model E analytic ultracentrifuge with schlieren optics at a protein concentration of 5-10 mg/ml in 0.14 M NaCl. Sedimentation coefficient values reported here are not corrected to zero concentration or water.
Amino acid analysis. Aliquots of peptides were hydrolyzed with constant boiling of 6 N HCl for 20 hr at 108°C. Whole reduced-alkylated protein was hydrolyzed in vacuo for 24 hr at 108°C with 6 N HCl. Amino acid analysis was performed on a Spinco model 120C amino acid analyzer.
NH,-tcrminal amino acid. The NH2-terminal amino acids of the yHCD-JM protein and of another 7yHCD (Craw) were determined by the method of Stark (11 (Fig. 2 a) . The antiserum was rendered specific for y-heavy polypeptide chains by absorption with kappa and lambda Bence Jones proteins. The J. M. paraprotein was shown to give a reaction of partial identity with normal IgG, of complete identity with normal Fcy, and of nonidentity with Faby, using the absorbed antiserum (Fig. 2 b) . Further (Fig. 3) . Minor differences exist that may reflect differences in Gm factors, as well as slight size differences between the protein of heavy chain disease and the artificially produced Fc-fragment. The similarity of these polypeptide chains is striking, however, and indicates that the H chain disease protein bears a close structural resemblance to the Fc -y3-fragment.
5. Amino acid analysis. Amino acid analysis of .yHCD-JM is recorded in Table I . The protein contains 6. NHs-Terminal studies. The NH2-terminal amino acid of yHCD-JM was glutamic acid and this was obtained in a yield of 66% by the Stark procedure. Additional amino acids such as serine and threonine were also obtained in low yield (9 and 6%, respectively). Similar analysis of yHCD-Craw showed that the predominant N-terminal residue was glycine, recovered with a 30% yield. Here other amino acids, aspartic acid (10%), glutamic acid (5%), leucine (10%) and alanine (5%) were also obtained. The low yields could result from losses during the procedure or from the presence of a blocked NH2 terminus of the proteins.
The NH2-terminal amino acids of yHCD-JM and yHCD-Craw were found to be in the open form and not in a blocked, cyclized, pyrollidone carboxylic acid (PCA) form. This was ascertained by digestion of 10 mg of heat-denatured urinary yHCD with chymotrypsin and by passing the digest through a Dowex-50 column. The effluent was collected, and an amino acid analysis performed. The same procedure was used for isolated serum .yHCD-JM paraprotein. No peptide was obtained for either urinary -yHCD or for serum yHCD-JM, thus ruling out a blocked amino terminal residue. These findings suggest that the NH2 terminus of -yHCD-JM and yHCD-Craw are unlike that of most whole heavy chains that generally occur in the cyclized PCA form.
Comparison of the NH2-terminal region of the yHCD-JM with normal y-chains was extended by attempts to isolate an NH2-terminal peptide. Pronase digest of the acetylated -yHCD-JM was passed twice through a Dowex-50 column and yielded a mixture of peptides that were separated from each other on paper by high voltage electrophoresis at pH 6.5. All these peptides were detected by a peptide bond stain but they failed to react with ninhydrin. The amino acid compositions and yields of these peptides are shown in Table II . Several explanations exist for the occurrence of this mixture of Pronase peptides. There may be true heterogeniety of the N-terminus in the J. M. paraprotein. Alternatively, some of the peptides may have passed through the Dowex column either because they were too acidic to be retained by the resin or because an amino-terminal glutamic acid or glutamine underwent cyclization to the PCA form. In any case, none of the isolated peptides resemble the N-terminal sequence of whole y-heavy chains obtained in our laboratory (16) or reported elsewhere (17).
(B) Cellular studies
Biosynthesis. In order to ascertain if the yHCD-JM is secreted as a heavy chain fragment, bone marrow cells from the patient were incubated in short-term culture with lysin-14C and isoleucine-"C. Supernatant fluid was collected, concentrated, and analyzed by radioimmunoelectrophoresis (Fig. 4) . A radioactive precipitin arc of fast gamma electrophoretic mobility was detected by using a polyvalent anti-immunoglobulin and specific anti-IgG serum. This arc is not present with anti-kappa or antilambda serums. These studies show that the patient's bone marow contains cells that secrete the yHCD of this disease. This is direct evidence that yHCD is not the result of extracellular proteolysis of a whole y-heavy chain.
Immunofluorescence. Immunofluorescent tests were performed to determine whether or not the cells synthesizing the yHCD also synthesized light polypeptide chains. Bone marrow and lymph node of patient J. M. had 7-10% cells that reacted with anti-y-serum but less chains. Similarly, bone marrow from a patient with a G-myeloma protein, with kappa light chains (Ben) showed about the same percentage of cells staining for kappa light chains as for .y-heavy chains. Double-labeling experiments were performed with J. M. tissues with various combinations of fluoresceinand rhodamine-conjugated antisera (Table IV) . Control experiments performed with bone marrow from a patient with a kappa-type G-myeloma protein revealed that about 90% of all fluorescent cells showed yellow fluorescence when stained with anti--yG plus anti-kappa sera (Table IV) . When anti-yG was used with anti-X, about 85-95% of cells showed only the fluorescence expected with the y-reagent alone.
Bone marrow from the heavy-chain disease patient showed from 85 to 92% fluorescent cells staining only for -y-heavy chains. At most, 14% of cells showed any evidence of reaction with light-chain antisera. Fluorescence was homogeneous throughout the cytoplasm of cells that appeared plasmacytic. No nuclear fluorescence was observed. These tests with J. M. tissue show that yHCD is synthesized in the absence of light chains.
Further studies were done to detect human IgG3-containing cells (Table V) . Since the IgG3-subclass represents only from 5 to 10% of serum IgG, it might be expected that from 5 to 10% of normal IgG-producing cells make IgG3. By contrast, in G3-myeloma and in heavy chain disease (J. M.), most of the plasma cells in the (18) . These data indicate that teins (1) (2) (3) (4) (5) 19) . The occurrence of about half of a there is a disturbance in the control of normal immunoy-heavy chain in HCD, which is related to the Fc-frag-globulin synthesis to the extent that structural genes for ment of IgG, raises important questions about the forma-light chains are not expressed in the involved cells. tion of this paraprotein. The biosynthetic findings in the A defect must also exist in synthesis of heavy polypresent study show that the HCD protein is a secreted peptide chains to account for the secretion of only a porproduct of cells present in the patient's bone marrow. tion of the molecule. Franklin (19) Another mechanism has been proposed by Prahl (23) who has suggested that in H chain disease, chain synthesis is initiated in a normal manner for whole H chain but that there is a large gene deletion in the Fd region. This suggestion arose from observations of the N-terminal tripeptide of -yHCD-Zu which has the sequence Glp-Val-Thr. This sequence is identical to the predominant N-terminal sequence of pooled human IgG heavy chains (17) . Our data in contrast, show that -yHCD-JM and yHCD-Craw differ at the NH2-terminal amino acid from normal y-polypeptide chains, having predominantly glutamic acid and glycine, respectively. Also, our data indicates that -yHCD-JM does not contain peptides resembling the reported N-terminal peptides of pooled y-heavy chains (17) or H chains of G-myeloma proteins (16, 17) . These data do not fit the hypothesis of deletion within the -y-polypeptide chain but indicate rather that the N-terminal portion of the normal chain is missing.
The observed heterogeneity of the N-terminus is consistent with the hypothesis that intracellular proteolysis cleaves the nascent heavy chain in the Fd region. It could be that heavy chains unprotected by light chains are sensitive to intracellular enzymes. The Fc-fragment might not be effected and presumably might be secreted from the cell. Using an absorbed antiserum (Fig. 2c) , an attempt was made to demonstrate Fd determinants in the J. M. tumor cells by immunofluorescence. Although some cells showed positive staining, this antiserum is not strictly specific for the Fd region. Since it has not been possible to exclude the possibility that Fd-fragments are also being made, it is important that they be sought in the future.
Two types of studies could test the proposed models.
Recent studies of the synthesis and assembly of immunoglobulin molecules have shown that heavy and light chains are synthesized on polysomes of different sizes (22, 24) . The identification of the size of polysomes responsible for H chain disease protein manufacture would indicate whether the whole or only part of the H chain was being synthesized. The size of the polysomes would presumably be independent of whether or not intracellular proteolytic enzymes cleaved an intact H chain. Secondly, it might be possible to determine the size of newly synthesized intracellular protein after a short pulse of radioactive amino acids followed by inhibition of all enzyme activity.4
Because of limitations in available J. M. tissue, these experiments could not be carried out. It is to be hoped that this kind of study will be feasible when another case of heavy chain disease is discovered so that definite information about the origin of this protein may be obtained.
